GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ningbo David Medical Device Co Ltd (SZSE:300314) » Definitions » ROCE %

Ningbo David Medical Device Co (SZSE:300314) ROCE % : 14.91% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Ningbo David Medical Device Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ningbo David Medical Device Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 14.91%.


Ningbo David Medical Device Co ROCE % Historical Data

The historical data trend for Ningbo David Medical Device Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo David Medical Device Co ROCE % Chart

Ningbo David Medical Device Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.58 11.40 8.94 10.84 14.81

Ningbo David Medical Device Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.03 16.41 12.35 9.38 14.91

Ningbo David Medical Device Co ROCE % Calculation

Ningbo David Medical Device Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=166.824/( ( (1252.695 - 176.63) + (1374.083 - 197.437) )/ 2 )
=166.824/( (1076.065+1176.646)/ 2 )
=166.824/1126.3555
=14.81 %

Ningbo David Medical Device Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=178.252/( ( (1374.083 - 197.437) + (1364.965 - 150.248) )/ 2 )
=178.252/( ( 1176.646 + 1214.717 )/ 2 )
=178.252/1195.6815
=14.91 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ningbo David Medical Device Co  (SZSE:300314) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Ningbo David Medical Device Co ROCE % Related Terms

Thank you for viewing the detailed overview of Ningbo David Medical Device Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ningbo David Medical Device Co (SZSE:300314) Business Description

Traded in Other Exchanges
N/A
Address
No.35, Jinxing Road, Binhai Industry Park, Ningbo, CHN, 315712
Ningbo David Medical Device Co Ltd operates in the medical device industry. The company specializes in an independent research and development, production and distribution of medical equipment. The main products of the company are infant incubator, transport incubator, infant radiant warmer, neonate bilirubin phototherapy equipment and infant resuscitator.
Executives
Ma Jian Min Executives
Chen Zai Hong Directors, executives
Chen Yun Qin Director
Mao Tian Yi Executives
Li Ze Dong Directors, Directors, and Executives
Lin Ding Yu Executives
Yu Yong Wei Directors, executives
Wang Yao Independent director
Xu Fang Fang Director

Ningbo David Medical Device Co (SZSE:300314) Headlines

No Headlines